Detect™ Covid-19 with confidence. PCR-quality results at home in 1 hour.
FOR USE UNDER FDA EMERGENCY USE AUTHORIZATION (EUA).
SARS-CoV-2 Variant Update
Detect™ conducts routine surveillance of emerging SARS-CoV-2 variant strains and will continue to monitor the effectiveness of our test for such variants. Based on our most recent bioinformatic analysis, the Detect test is expected to recognize all currently known Variants of Concern including Omicron and Omicron subvariants [BA.2, BA.4 & BA.5].Read more
97.3% accuracy and no false positives.
Results in 1 hour. Nothing to mail.
Comfortable nostril swab for adults and children over 2.
Expected to recognize all currently circulating Variants of Concern.
Suitable for home, offices, schools, and travel.
When interpreted correctly in a clinical study.
Stay in the Loop
Join our email list to keep up with all things Detect™.
Detect™ can identify Covid-19 at lower viral loads than antigen tests, allowing for earlier detection.
In clinical studies, the Detect™ test was comparable to PCR tests, with 97.3% accuracy.
Designed for comfort with a quick and painless nostril swab.
Test yourself at home. 5 minutes of hands-on time. Results in 1 hour.
Detect™ with confidence
Expected to recognize all Variants of Concern, including Delta and Omicron (BA.1 and BA.2). We're constantly monitoring new variants to maintain our test performance
Supported by the NIH Rapid Acceleration of Diagnostics Initiative (RADx).
Detect™ was awarded an $8.1M contract to scale manufacturing and help fulfill unmet national testing needs.
Testing for everyone
The people behind Detect
Jonathan Rothberg, PhD
Detect founder Dr. Jonathan Rothberg has a strong track record of building successful companies that solve important scientific challenges. He is best known for inventing and commercializing massively parallel DNA sequencing, which earned him a National Medal of Technology and Innovation from President Obama, the nation’s highest honor for technological achievement. He is the founder of multiple health technology companies, including CuraGen, 454 Life Sciences, Ion Torrent, RainDance Technologies, ClariFI and, more recently Butterfly Network (the world’s most accessible and fastest-selling ultrasound device), Quantum-Si (the first single-molecule protein sequencing platform), and Hyperfine Research (the world’s first truly portable MRI machine).
The Detect team brings together the best and brightest from molecular biology, consumer technology, high-volume manufacturing, and product design. We are motivated to solve the hardest problems and to save lives through technology.Join us
News & Announcements
This once-in-a-hundred-years pandemic has fundamentally changed the world. Our team has set out to solve the testing problem and help reopen society. In doing so, we are launching a new industry and a new human behavior: testing as part of daily life, accessible to everyone around the world. Covid-19 today, any pathogen tomorrow.Dr. Jonathan Rothberg, Detect Founder